Background Opioid dependence is associated with substantial health and social burdens,
and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for …

Abstract The United States is in the midst of a national opioid epidemic. Physicians are
encouraged both to prevent and treat opioid-use disorders (OUDs). Although there are 3 …

We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …

ABSTRACT Background Background: In response to the COVID-19 pandemic, the US
Substance Abuse and Mental Health Services Administration (SAMHSA) allowed for an …

Background Due to the COVID-19 pandemic, the Substance Abuse and Mental Health
Services Administration (SAMHSA) has relaxed restrictions on methadone treatment in the …

Objective: Extensive exposure to prescription-type opioids has resulted in major harm
worldwide, calling for better-adapted approaches to opioid agonist therapy. The authors …

Abuse and Mental Health Services Administration (SAMHSA) released guidance to opioid
treatment programs relaxing some of the MMT restrictions that had been in place for more …

Background Substance use is disproportionately high among people who are homeless or
vulnerably housed. We performed a systematic overview of reviews examining the effects of …

Introduction: Management of patients with opioid use disorder (OUD) commonly includes
opioid agonist therapy (OAT) as a part of an integrated treatment plan. These interventions …

Background Historical restrictions on take-home medications for opioid use disorder have
generated considerable debate. The COVID-19 pandemic shifted the perceived risks and …